Poonawalla Fincorp Ltd
- Market Cap ₹ 27,662 Cr.
- Current Price ₹ 356
- High / Low ₹ 520 / 270
- Stock P/E 66.3
- Book Value ₹ 103
- Dividend Yield 0.56 %
- ROCE 11.1 %
- ROE 15.6 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 32.7% CAGR over last 5 years
Cons
- Stock is trading at 3.45 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 11.6% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -10.6%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Part of BSE 500 BSE 250 LargeMidCap Index Nifty LargeMidcap 250 Nifty Midcap 150 Nifty MidSmallcap 400
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,584 | 1,856 | 2,030 | 2,120 | 1,993 | 2,063 | 2,234 | 2,178 | 1,849 | 1,536 | 2,193 | 5,827 | 3,644 |
Interest | 887 | 1,055 | 1,061 | 998 | 943 | 1,013 | 1,018 | 1,124 | 875 | 509 | 595 | 955 | 1,176 |
503 | 609 | 774 | 836 | 1,025 | 800 | 797 | 989 | 1,723 | 623 | 607 | 817 | 1,951 | |
Financing Profit | 194 | 192 | 194 | 286 | 25 | 251 | 419 | 64 | -748 | 404 | 990 | 4,055 | 517 |
Financing Margin % | 12% | 10% | 10% | 14% | 1% | 12% | 19% | 3% | -40% | 26% | 45% | 70% | 14% |
22 | 20 | 15 | 19 | 34 | 35 | 34 | 41 | 28 | 30 | -162 | -1,457 | 44 | |
Depreciation | 37 | 33 | 35 | 39 | 48 | 49 | 50 | 72 | 52 | 49 | 61 | 59 | 59 |
Profit before tax | 179 | 178 | 175 | 266 | 11 | 237 | 403 | 34 | -773 | 385 | 767 | 2,539 | 501 |
Tax % | 31% | 24% | 15% | 30% | 43% | 15% | 32% | 129% | -25% | 24% | 24% | 19% | |
123 | 136 | 149 | 187 | 6 | 201 | 275 | -10 | -578 | 293 | 585 | 2,056 | 417 | |
EPS in Rs | 6.46 | 7.13 | 7.83 | 7.90 | 0.26 | 8.49 | 10.22 | -0.37 | -21.45 | 3.83 | 7.62 | 26.54 | 5.43 |
Dividend Payout % | 12% | 11% | 10% | 10% | 311% | 9% | 8% | 0% | 0% | 10% | 26% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 21% |
3 Years: | 47% |
TTM: | 45% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 33% |
3 Years: | 58% |
TTM: | -53% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 51% |
3 Years: | 21% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | 12% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 38 | 38 | 38 | 47 | 47 | 47 | 54 | 54 | 54 | 153 | 154 | 154 | 155 |
Reserves | 1,136 | 1,226 | 1,345 | 1,984 | 1,990 | 1,763 | 2,502 | 2,461 | 1,888 | 5,562 | 6,271 | 7,962 | 7,861 |
9,593 | 8,949 | 9,821 | 9,838 | 8,491 | 11,098 | 11,750 | 10,060 | 7,949 | 6,773 | 11,209 | 15,216 | 18,294 | |
975 | 1,105 | 1,107 | 1,039 | 891 | 659 | 682 | 380 | 451 | 322 | 388 | 704 | 643 | |
Total Liabilities | 11,742 | 11,318 | 12,312 | 12,909 | 11,419 | 13,568 | 14,988 | 12,955 | 10,342 | 12,810 | 18,022 | 24,036 | 26,952 |
166 | 157 | 195 | 202 | 211 | 191 | 184 | 221 | 171 | 174 | 207 | 194 | 224 | |
CWIP | 8 | 25 | 8 | 12 | 5 | 1 | 4 | 6 | 0 | 0 | 5 | 0 | 0 |
Investments | 285 | 321 | 241 | 458 | 580 | 306 | 302 | 402 | 429 | 820 | 510 | 878 | 1,239 |
11,282 | 10,815 | 11,867 | 12,237 | 10,623 | 13,070 | 14,498 | 12,326 | 9,742 | 11,815 | 17,300 | 22,963 | 25,488 | |
Total Assets | 11,742 | 11,318 | 12,312 | 12,909 | 11,419 | 13,568 | 14,988 | 12,955 | 10,342 | 12,810 | 18,022 | 24,036 | 26,952 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
807 | 1,260 | 83 | 714 | 2,406 | 211 | -584 | 1,661 | 2,088 | -1,649 | -3,900 | -6,986 | |
-285 | -76 | 22 | -244 | -180 | -36 | -77 | -241 | 93 | -525 | -177 | 2,993 | |
-6 | -1,696 | -201 | -498 | -2,301 | -209 | 1,135 | -1,782 | -2,120 | 2,244 | 4,344 | 3,647 | |
Net Cash Flow | 516 | -512 | -96 | -28 | -75 | -34 | 475 | -363 | 60 | 70 | 266 | -346 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROE % | 11% | 11% | 11% | 11% | 0% | 10% | 13% | -0% | -26% | 8% | 9% | 16% |
Documents
Announcements
-
Intimation W.R.T Grant Of Stock Options Under Employee Stock Option Plan- 2024 - Scheme-II.
20 Nov - Grant of 10,000 stock options under ESOP-2024.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 20 Nov
-
Intimation W.R.T Grant Of Stock Options Under Employee Stock Option Plan- 2024 - Scheme-II
11 Nov - Grant of 60,000 stock options under ESOP-2024.
-
Announcement under Regulation 30 (LODR)-Allotment
7 Nov - Approval of allotment of 31,000 non-convertible debentures.
-
Disclosure Under Regulation 30 And 51 Of The SEBI Listing Regulations-Issue Of Non-Convertible Debentures.
4 Nov - Approval for issuance of non-convertible debentures worth ₹500 Crores.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from nse
Concalls
-
Oct 2024Transcript PPT REC
-
Jul 2024Transcript PPT REC
-
Apr 2024Transcript PPT REC
-
Jan 2024Transcript PPT REC
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT REC
-
Apr 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Sep 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Feb 2020TranscriptNotesPPT
-
Jan 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
May 2019Transcript PPT
-
Jan 2019TranscriptNotesPPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Mar 2018TranscriptPPT
-
Feb 2018Transcript PPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017Transcript PPT
-
Jan 2017TranscriptPPT
-
Nov 2016Transcript PPT
-
Aug 2016Transcript PPT
-
May 2016Transcript PPT
-
Feb 2016Transcript PPT
Promoter
As of Sep 2024, the Cyrus Poonawalla group holds a 61.87% stake in the company through Rising Sun Holdings Private Limited (RSHPL). RSHPL is the core investment company of the group, having investments in insurance, retail, pharma, and the financial services segment. RSHPL made an equity infusion of Rs. 3,206 Cr in the company in May 2021. [1] [2]